These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

184 related articles for article (PubMed ID: 7813585)

  • 1. Are the cardiovascular effects and '5-HT syndrome' induced by MDL 73,975 and flesinoxan in the dog mediated by 5-HT1A receptors?
    Di Francesco GF
    Eur J Pharmacol; 1994 Sep; 262(3):205-15. PubMed ID: 7813585
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cardiovascular effects of the 5-HT1A receptor ligand, MDL 73005EF, in conscious spontaneously hypertensive rats.
    Buisson-Defferier S; Van den Buuse M
    Eur J Pharmacol; 1992 Nov; 223(2-3):133-41. PubMed ID: 1362161
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Differential cardiovascular effects of 8-hydroxy-2-(di-n-propylamino) tetralin (8-OH-DPAT), flesinoxan, 5-methyl-urapidil and MDL 75,608A in conscious spontaneously hypertensive rats.
    Buisson-Defferier S; Hibert M; van den Buuse M
    Fundam Clin Pharmacol; 1993; 7(9):499-511. PubMed ID: 7906241
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The putative 5-HT1A receptor antagonist DU125530 blocks the discriminative stimulus of the 5-HT1A receptor agonist flesinoxan in pigeons.
    Mos J; Van Hest A; Van Drimmelen M; Herremans AH; Olivier B
    Eur J Pharmacol; 1997 May; 325(2-3):145-53. PubMed ID: 9163561
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cardiovascular and side effects of flesinoxan in conscious hypertensive dogs. Modulation by prazosin.
    Huber S; Grohs JG; Raberger G
    Eur J Pharmacol; 1991 Sep; 202(1):1-7. PubMed ID: 1786795
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effect of sustained administration of the 5-HT1A receptor agonist flesinoxan on rat 5-HT neurotransmission.
    Haddjeri N; Ortemann C; de Montigny C; Blier P
    Eur Neuropsychopharmacol; 1999 Sep; 9(5):427-40. PubMed ID: 10523050
    [TBL] [Abstract][Full Text] [Related]  

  • 7. 5-HT1A receptors and the tail-flick response. VI. Intrinsic alpha 1A-adrenoceptor antagonist properties can mask the actions of 5-HT1A receptor agonists in the spontaneous tail-flick paradigm.
    Millan MJ; Rivet JM; Gobert A; Canton H; Veiga S; Bervoets K
    J Pharmacol Exp Ther; 1994 Apr; 269(1):121-31. PubMed ID: 7909555
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cardiovascular effects of SL65.0472, a 5-HT receptor antagonist.
    O'Connor SE; Grosset A; La Rochelle CD; Gautier E; Bidouard JP; Robineau P; Caille D; Janiak P
    Eur J Pharmacol; 2001 Mar; 414(2-3):259-69. PubMed ID: 11239927
    [TBL] [Abstract][Full Text] [Related]  

  • 9. GR46611 potentiates 5-HT1A receptor-mediated locomotor activity in the guinea pig.
    O'Neill MF; Sanger GJ
    Eur J Pharmacol; 1999 Apr; 370(2):85-92. PubMed ID: 10323255
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Influence of 5-HT1A receptors on central noradrenergic activity: microdialysis studies using (+/-)-MDL 73005EF and its enantiomers.
    Hajós-Korcsok E; McQuade R; Sharp T
    Neuropharmacology; 1999 Feb; 38(2):299-306. PubMed ID: 10218872
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Antiemetic effects of flesinoxan in cats: comparisons with 8-hydroxy-2-(di-n-propylamino)tetralin.
    Lucot JB
    Eur J Pharmacol; 1994 Feb; 253(1-2):53-60. PubMed ID: 8013549
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pharmacological analysis of the cardiac effects of 5-HT and some 5-HT receptor agonists in the pithed rat.
    Dabiré H; Chaouche-Teyara K; Cherqui C; Fournier B; Schmitt H
    Fundam Clin Pharmacol; 1992; 6(6):237-45. PubMed ID: 1336759
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pharmacological profile of the receptors that mediate external carotid vasoconstriction by 5-HT in vagosympathectomized dogs.
    Villalón CM; Ramírez-San Juan E; Castillo C; Castillo E; López-Muñoz FJ; Terrón JA
    Br J Pharmacol; 1995 Nov; 116(6):2778-84. PubMed ID: 8591004
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Differential effects of WAY-100135 on the decrease in 5-hydroxytryptamine release induced by buspirone and NAN-190.
    Routledge C; Gurling J; Ashworth-Preece MA; Dourish CT
    Eur J Pharmacol; 1995 Apr; 276(3):281-4. PubMed ID: 7601215
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The 5-HT1-like receptor mediating the increase in canine external carotid blood flow: close resemblance to the 5-HT1D subtype.
    Villalón CM; Terrón JA
    Br J Pharmacol; 1994 Sep; 113(1):13-20. PubMed ID: 7812603
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Central administration of 5-HT activates 5-HT1A receptors to cause sympathoexcitation and 5-HT2/5-HT1C receptors to release vasopressin in anaesthetized rats.
    Anderson IK; Martin GR; Ramage AG
    Br J Pharmacol; 1992 Dec; 107(4):1020-8. PubMed ID: 1467825
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pharmacological characterization of in vivo properties of putative mixed 5-HT1A agonist/5-HT(2A/2C) antagonist anxiolytics. II. Drug discrimination and behavioral observation studies in rats.
    Kleven MS; Assié MB; Koek W
    J Pharmacol Exp Ther; 1997 Aug; 282(2):747-59. PubMed ID: 9262338
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Induction of hypothermia as a model of 5-hydroxytryptamine1A receptor-mediated activity in the rat: a pharmacological characterization of the actions of novel agonists and antagonists.
    Millan MJ; Rivet JM; Canton H; Le Marouille-Girardon S; Gobert A
    J Pharmacol Exp Ther; 1993 Mar; 264(3):1364-76. PubMed ID: 8450471
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparison of the cardiovascular effects of the 5-HT1A receptor agonist flesinoxan with that of 8-OH-DPAT in the rat.
    Dreteler GH; Wouters W; Saxena PR
    Eur J Pharmacol; 1990 May; 180(2-3):339-49. PubMed ID: 2142096
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Discriminative stimulus effects of 8-OH-DPAT in pigeons: antagonism studies with the putative 5-HT1A receptor antagonists BMY 7378 and NAN-190.
    Barrett JE; Gleeson S
    Eur J Pharmacol; 1992 Jul; 217(2-3):163-71. PubMed ID: 1425937
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.